F.D.A. Says Pfizer Vaccine’s Benefits Outweigh Key Risks in Children 5 to 11news2021-10-23T03:18:50+00:00October 23rd, 2021|The New York Times|
Qué pasa si combino vacunas en la dosis de refuerzonews2021-10-21T20:14:29+00:00October 21st, 2021|The New York Times|
F.D.A. Authorizes Moderna and Johnson & Johnson Booster Shotsnews2021-10-21T01:49:57+00:00October 21st, 2021|The New York Times|
Sales of Biogen’s Alzheimer’s Drug Fall Short of Expectationsnews2021-10-20T20:06:11+00:00October 20th, 2021|The New York Times|
Mix-and-Match Covid Boosters: Why They Just Might Worknews2021-10-19T18:18:14+00:00October 19th, 2021|The New York Times|
F.D.A. to Allow ‘Mix and Match’ Approach for Covid Booster Shotsnews2021-10-18T23:32:29+00:00October 18th, 2021|The New York Times|
F.D.A. Panel Recommends Moderna Booster for Certain Groupsnews2021-10-15T02:10:00+00:00October 15th, 2021|The New York Times|
F.D.A. Panel Greenlights Moderna Boosters for High-Risk Individualsnews2021-10-14T20:51:21+00:00October 14th, 2021|The New York Times|
Where Things Stand on Boosters for Three Vaccines in the U.S.news2021-10-14T19:36:30+00:00October 14th, 2021|The New York Times|
Merck Asks F.D.A. for Emergency Approval of Covid Pillnews2021-10-12T04:25:38+00:00October 12th, 2021|The New York Times|
